Ding Zhao is an Associate Professor in Mechanical Engineering at Carnegie Mellon University (CMU), with cross-appointments in Computer Science, Robotics Institute, CyLab Security & Privacy Institute, and Scott Institute for Energy Innovation. He directs the CMU Safe AI Laboratory, pioneering research in trustworthy AI for autonomous vehicles, robotics, and healthcare. His work emphasizes robustness, safety, and ethical deployment of AI systems. Education: • Ph.D. in Mechanical Engineering, University of Michigan (2016) • B.S. in Automotive Engineering, Jilin University (2010) Research Interests: Zhao's lab bridges machine learning theory and engineering to develop AI for high-stakes applications. Key areas include: trustworthy AI generalization, safety-critical decision-making, generative AI for digital twins, and physical AI in mobility/healthcare. His long-term mission is to create "trustworthy AI generalists" deployable in real-world critical systems. Awards & Honors: NSF CAREER Award MIT Technology Review 35 under 35 China IEEE George N. Saridis Best Paper Award Ford/Carnegie-Bosch/Toyota Industrial Fellowships Qualcomm Innovation Award Advising & Grants: He mentors 13+ PhD and 30+ Master’s students, with alumni at NVIDIA, Meta, Stanford, and Tsinghua University. His lab collaborates with Google, Amazon, Ford, Mayo Clinic, and received grants from NSF, DOT, Rolls-Royce, and Bosch. Courses taught include Trustworthy AI and Modern Control for Robotics . Lab & Projects: The Safe AI Lab develops: Safe Robotic Foundation Models (LocoMan), generative AI for autonomous driving (SafeBench), cardiac diagnostics (Heart-2), multi-agent safety systems, and robotic tool innovation (RoboTool). Projects target landslide monitoring, AV safety with Pittsburgh, and energy grid resilience.
Prof. Abbas Samani is a Professor at the Department of Electrical and Computer Engineering and holds a joint appointment in the Department of Medical Biophysics at Western University . He is a core faculty member of the Biomedical Engineering Graduate Program and an Associate Scientist at Imaging Research Laboratories of Robarts Research Institute . His academic journey includes a Ph.D. from the University of Waterloo, an M.Sc. from the University of Tehran, and a B.Sc. from Amirkabir University of Technology. His research focuses on biological tissue computational modeling and its applications in medical imaging, intervention, and image analysis . He develops computer/image-assisted tools for minimally invasive disease diagnosis and therapy , targeting heart disease, cancer, and lung disease . Key projects include myocardium biomechanical modeling , handheld medical devices for breast cancer screening , and lung disease diagnostics via CT image segmentation . His recent publications emphasize ultrasound elastography , finite element modeling , and inverse problems in biomechanics , primarily in journals like IEEE Transactions on Computational Imaging and Translational Oncology . His work spans both computational modeling and medical device development . Selected Graduate Supervision : Ph.D. Candidates : Seyed Hassan Haddad, Elham Karami, Seyed Mohammad Hesabgar Graduated Ph.D. Students : Ali Sadeghi Naini, Seyed Reza Mousavi M.Sc. Students : Cristian Linte, Patrick Courtis, Joseph O'Hagan, Hatef Mehrabian, Hirad Karimi, Hosein Amooshahi, Seyed Mohammad Hesabgar, Nastaran Ghadarghadr, Shadi Shavakh, Ehsan Salamati, Ehsan Omidi Teaching Contributions : Graduate: BME9519B/CAMI9519B/ECE9202B/ECE9022B - Advanced Image Processing and Analysis , MBP9530A - Human Biomechanics and Biomedical Applications Undergraduate: ECE4438B - Advanced Image Processing and Analysis , ES1050 - Introductory Engineering Design and Innovation Studio , MBP3330F - Human Biomechanics and Biomedical Applications Research Affiliations : Robarts Research Institute - Associate Scientist at Imaging Research Laboratories Western University - Core Faculty, Biomedical Engineering Graduate Program
Dr. Peter L. Latchman serves as a Professor in the Department of Health and Movement Sciences at Southern Connecticut State University. He holds a Doctorate in Applied Physiology from Columbia University and is an Overseas Fellow of the Royal Society of Medicine. His academic career spans decades of research in autonomic cardiovascular regulation with applications to diverse populations including Young adults post-COVID-19 infection Ethnic disparities in baroreflex sensitivity Autonomic dysfunction in obese children Central hemodynamic analysis Recent scholarship focuses on autonomic modulation patterns and their implications for cardiovascular health, while his teaching portfolio encompasses both graduate and undergraduate courses in exercise physiology, cardiac rehabilitation, and medical terminology. Dr. Latchman has delivered presentations at international symposia on topics including Baroreflex sensitivity in African American populations Effects of aerobic capacity on autonomic recovery Vascular physiological assessment techniques Scientific contributions include Overseas Fellowship, Royal Society of Medicine $10,000 grant for cardiovascular assessment in autistic children (2023) He maintains active research collaborations with institutions such as East China Normal University and Hong Kong Baptist University.
Gaetano Valenza is an Associate Professor of Bioengineering at the University of Pisa, Italy, where he leads the Neuro-Cardiovascular Intelligence Lab at the Enrico Piaggio Research Centre. He holds affiliations with the Neuroscience Statistics Research Laboratory at MIT and has served as a Research Fellow at Harvard Medical School and Massachusetts General Hospital. His academic work spans bioengineering, computational physiology, and affective computing. His research focuses on statistical and nonlinear biomedical signal and image processing , cardiovascular and neural modeling , and physiologically interpretable artificial intelligence . He develops wearable systems for physiological monitoring, with applications in autonomic nervous system assessment, brain-heart interactions, and mental health. His work has led to novel metrics such as the Sympathetic and Parasympathetic activity indices derived from ECG. The 15 most recent publications reflect a consistent trend in brain-heart interplay , complexity analysis of physiological signals , explainable AI in healthcare , and virtual reality applications in mental health . His work integrates advanced signal processing, nonlinear dynamics, and machine learning to decode emotional and cognitive states from physiological data. Dr. Valenza is a Senior Member of IEEE and serves on several technical committees. He is an active editorial leader, currently serving as Associate Editor for IEEE-EMBC , Plos One , Complexity , and Scientific Reports , and has guest-edited special issues in Philosophical Transactions of the Royal Society A and IEEE Journal of Biomedical and Health Informatics . He has led or participated in numerous international research projects, including FP7 and H2020 initiatives such as NEVERMIND and EXPERIENCE. He teaches courses in Biostatistics, Probability & Biostatistics, and Advanced Image Processing at the University of Pisa. As lab head and project coordinator, he leads a multidisciplinary team working on neuro-cardiovascular intelligence, wearable systems, and AI-driven mental health interventions.
Todd A. Alonzo is a Professor of Research in the Department of Preventive Medicine at the University of Southern California . As Group Statistician for the Children's Oncology Group , he focuses on statistical methods for biomarker analysis, medical diagnostic testing, and clinical trial design in pediatric acute myeloid leukemia (AML). Education: B.S. in Statistics, California State Polytechnic University (1994) MS and PhD in Biostatistics, University of Washington (1997, 2000) Research Interests include: Development of statistical frameworks for diagnostic accuracy Genomic and proteomic profiling in AML Pharmacogenomic score systems for chemotherapy response Non-inferiority trial design in low-event-rate settings Health disparities in pediatric oncology Scientific Awards : Fellow, American Statistical Association (2018) Outstanding Teacher Award, International Society for Magnetic Resonance in Medicine (2017) NIH Predoctoral Cardiovascular Biostatistics Training Grant (1995) ENAR Biometrics Society Distinguished Student Paper Award (1999) WNAR Biometrics Society Best Student Oral Presentation (1999) Leadership & Service includes editorial board memberships (Biometrics, Pediatric Blood & Cancer, Biometrical Journal), reviewer for 30+ scientific journals, and roles on multiple Data Safety and Monitoring Boards. He served as President of the International Biometric Society Western Northern America Region (WNAR) in 2009.
Mathias Funk is an Associate Professor in the Industrial Design department at Eindhoven University of Technology (TU/e), leading the Things Ecology lab. His research focuses on designing with data and systems behavior, particularly in IoT and medical technology contexts. He co-founded UXsuite GmbH and developed the OOCSI communication framework. With a PhD in Electrical Engineering from TU/e (2011), Funk has held academic roles since 2013, including postdoctoral positions in Electrical Engineering and Industrial Design. He teaches courses like 'Data-enabled design' and supervises projects on AI, data foundry, and OOCSI applications. His work bridges engineering and design, addressing sustainability and human values through systemic design approaches. Education: PhD in Electrical Engineering, TU/e (2011) Computer Science background from RWTH Aachen Postdoc at TU/e's Electrical Engineering and Industrial Design departments Research Interests: Data-driven design methodologies, IoT systems, medical technology innovation, sustainable design practices, and interactive systems for musical expression. Recent work emphasizes telemonitoring efficacy in heart failure care and federated learning applications. Awards: Best Paper Award (2014) Honorable Mention (2021) Grants/Projects: Leading initiatives like MEDICAID (medtech solutions), ACACIA (interpretable AI), and Data-Driven Servitizing in Professional Printing. Active in clinical workflow prototyping and cardiovascular disease detection projects. Lab Activities: Manages the Things Ecology lab, focusing on systemic design challenges in smart ecosystems. Collaborates internationally through spin-offs and visiting lectureships.
Javad Dargahi is a Professor of Mechanical, Industrial and Aerospace Engineering at Concordia University, Montreal. His research focuses on haptic sensors, robotic systems for minimally invasive surgery, and smart sensor fabrication using micromachining and piezoelectric polymers. He leads projects in teletaction, embedded force sensing for soft robots, and medical device innovation. Research interests include tactile sensor design for robots and endoscopes, nonlinear impedance matching in surgical robotics, and deep learning-driven force estimation for catheters. His work bridges mechanical engineering with biomedical applications, emphasizing safety and precision in interventional surgeries. Recent publications explore multitask neural architectures for intracardiac catheters, real-time force control algorithms, and biomimetic soft robotics. His lab develops miniature optical sensors and stiffness-adaptive systems for surgical tools, with applications in cardiac ablation and vascular navigation.
Laura Munoz is an Associate Professor in the School of Mathematics and Statistics at the Rochester Institute of Technology (RIT), within the College of Science. She holds a BS from the California Institute of Technology and a Ph.D. from the University of California at Berkeley. Her research focuses on mathematical biology, dynamical systems, applied control theory, and cardiac electrophysiology, with a particular emphasis on understanding mechanisms underlying cardiac arrhythmias through mathematical modeling and computational methods. Her work explores topics such as ephaptic coupling in cardiac tissue, controllability of cardiac alternans, and the role of calcium dynamics in arrhythmogenesis. Recent studies include analyzing discordant alternans mechanisms and their link to ventricular fibrillation, as well as developing state estimation techniques for cardiac ionic models using Kalman filters. Munoz has published extensively in journals like Physical Review Letters , Chaos , and Computers in Biology and Medicine , and has presented at conferences such as the SIAM Conference on the Life Sciences. Munoz currently teaches courses such as Linear Algebra, Complex Variables, Mathematical Modeling I, and Mathematical Biology, emphasizing the application of mathematical tools to real-world biological systems. Her research integrates principles from applied mathematics, control theory, and computational biology to advance understanding of cardiac physiology and disease.
Juliane Nguyen, PhD, is a Professor in the Department of Pharmacoengineering and Molecular Pharmaceutics at the UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill. She serves as Vice Chair and Director of Graduate Admissions in her department and holds an adjunct appointment as Professor of Biomedical Engineering. Dr. Nguyen is also a member of the UNC Lineberger Comprehensive Cancer Center, where she applies molecular engineering approaches to develop innovative therapeutic solutions. Dr. Nguyen's research focuses on molecular engineering to advance protein-based therapeutics, live biotherapeutics (including engineered probiotic yeast), and extracellular vesicles. Her lab develops cutting-edge technologies to treat diverse conditions including cancer, myocardial infarction, chemotherapy-induced cardiotoxicity, and inflammatory bowel diseases. Her interdisciplinary approach integrates molecular engineering, pharmaceutical sciences, and bioinformatics to create complex biologics with exceptional safety and efficacy profiles. Key research areas include developing therapeutics for cardiac repair, genetically encoded materials targeting tumor-associated macrophages, live biotherapeutics for inflammatory bowel diseases using engineered probiotic yeast, and auxetic patches for dynamic organ repair. Analysis of Dr. Nguyen's recent publications reveals a strong focus on translational research with significant contributions to cardiac repair technologies, cancer immunotherapy, inflammatory bowel disease treatments, and advanced biomaterials. Her work consistently bridges fundamental molecular engineering with clinical applications, particularly in the areas of targeted drug delivery, extracellular vesicle therapeutics, and engineered live biotherapeutics. The research demonstrates a clear trajectory toward developing clinically viable solutions for previously challenging medical conditions. Dr. Nguyen has received numerous prestigious awards and honors including the NSF CAREER Award (2018), Eshelman Innovation Award (2020), and recognition as a Fellow of the Controlled Release Society (2023). She was appointed as a Standing Member of the NIH Drug and Biologic Therapeutic Delivery Study Section (2023-2025) and serves as Executive Editor of Advanced Drug Delivery Reviews since 2021. Her Galenus Guest Professorship at ETH Zuerich (2024) and keynotes at major conferences highlight her international recognition in the field. As Director of Graduate Admissions and an active mentor, Dr. Nguyen has advised numerous PhD and Master's students who have co-authored significant publications with her. Her research is supported by competitive grants including the NSF CAREER Award and other NIH-funded projects. The Nguyen Lab maintains strong collaborations across disciplines, particularly with cardiology, oncology, and biomedical engineering researchers. She leads an interdisciplinary team focused on translating molecular engineering breakthroughs into clinically impactful therapies. The Nguyen Lab operates as a dynamic, interdisciplinary research environment combining expertise in molecular engineering, pharmaceutical sciences, and bioinformatics. The lab's mission is to revolutionize medicine by developing next-generation therapeutics that target diseases at the molecular level. Current projects focus on translating cutting-edge research into life-changing therapies for patients suffering from cancer, myocardial infarction, colitis, and other challenging conditions. The lab's innovative approach to biomolecular engineering positions it at the forefront of developing safe, effective, and personalized therapeutic solutions.
Prof. Dr. Stefan Luther is a Max Planck Research Group leader (W2, tenured since 2013) at the Max Planck Institute for Dynamics and Self-Organization, Göttingen, and an Honorarprofessor at the Faculty of Physics, University of Göttingen. He holds adjunct roles as Adjunct Associate Professor at Cornell University (2009–2012) and Northeastern University (2016–2018), and serves as DZHK-Professor at the Institute of Pharmacology and Toxicology, University Medical Center Göttingen. His research focuses on nonlinear spatiotemporal dynamics in excitable biological media, particularly cardiac arrhythmias. He pioneered 4D imaging of heart function and developed algorithms for optogenetic and electrical control of arrhythmias. Translational efforts span basic research to preclinical and clinical studies. Education includes a Diplom in Physics (1997) and PhD (2000) from Georg-August-University, Göttingen. Postdoctoral training followed at the University of Twente (2001–2004) and Cornell University’s LASSP (2004–2006). His lab, the Biomedical Physics group, explores electromechanical coupling in cardiac systems and develops novel therapeutic approaches. Collaborations include work on computational modeling, uncertainty quantification in dynamical systems, and fluid dynamics of multiphase flows.
Una-May O'Reilly is a Principal Research Scientist at MIT's Computer Science and Artificial Intelligence Laboratory (CSAIL), leading the ALFA group. She holds a PhD in Computer Science from Carleton University (1995), with prior roles including a postdoctoral appointment at MIT's Artificial Intelligence Laboratory. Her research focuses on cybersecurity, adversarial AI, software security, and disinformation dynamics, applying evolutionary algorithms and machine learning to address arms races in cyber defense and societal challenges like climate change communication. Education: B.Sc., University of Calgary M.C.S., Carleton University Ph.D., Carleton University (1995) Research Interests: Adversarial machine learning for secure systems Coevolutionary algorithms in cybersecurity and healthcare Program comprehension via neuroscience and AI Climate disinformation mitigation on social media Large language model applications in code synthesis and threat hunting Key Projects: Adversarial Cyber Security : Modeling cyber attack-defense arms races GIGABEATS : AI-driven medical sensor data analysis for critical care MOOC Learner Project : Data science for online education insights Awards: EvoStar Award (2013) for contributions to evolutionary computation Fellow of ACM Sig-EVO Leadership & Service: Co-founder and Vice-Chair of ACM Sig-EVO Former Chair of GECCO (2005), major evolutionary computation conference Editorial roles in Evolutionary Computation and Genetic Programming and Evolvable Machines Labs & Groups: Leads the AnyScale Learning for All (ALFA) group at CSAIL, focusing on scalable AI for cybersecurity, healthcare, and education.
Hsueh-Chia Chang is the Bayer Professor of Chemical Engineering in the Department of Chemical and Biomolecular Engineering at the University of Notre Dame's College of Engineering. He also holds a concurrent faculty position in the Department of Aerospace and Mechanical Engineering. As Principal Investigator of the Chang Lab, he leads cutting-edge research in microfluidic and nanofluidic technologies for biomedical applications. Prof. Chang received his B.S. in Chemical Engineering from Caltech in 1976, followed by M.S. and Ph.D. degrees in Chemical Engineering from Princeton University in 1977 and 1980, respectively. His academic journey has established him as a leader in the field of microfluidics and biosensing technologies. Chang's research focuses on developing low-cost liquid biopsy nanotechnologies for cancer screening and therapy management. His lab specializes in microfluidic and nanofluidic research coupled with electrokinetics, optics, plasmonics and acoustics for biosensing applications. Key research areas include Electrokinetics & Biosensing, Optics & Plasmonics, Nanoelectrokinetics, and Droplet Microfluidics. The Chang Lab has developed innovative platforms that can isolate and sort tumor cells, exosomes, microvesicles, lipoproteins, and stress granules from blood samples, then lyse these structures to release RNA/protein biomarkers for detection and quantification. His recent publications reveal a strong focus on extracellular vesicle diagnostics, cancer biomarker detection, and point-of-care diagnostic technologies. The research spans multiple disciplines including oncology, cardiology, and neurology, with applications for pancreatic, liver, breast, ovarian, and lung cancers as well as myocardial infarction diagnosis. Fellow of American Institute of Medical and Biological Engineering (2025) Provost Research Achievement Award, Notre Dame (2024) Fellow of the National Academy of Inventors (2020) Lifetime Achievement Award, American Electrophoresis Society (2019) Fellow of the American Physical Society (1997) Presidential Young Investigator Award, NSF (1985) Prof. Chang has advised over 50 PhD students and postdocs who have gone on to prominent positions in academia and industry. His lab has secured significant funding and has commercialized several technologies through startups like Aopia Biosciences, which launched NanoEx at ISEV 2024. The Chang Lab maintains active collaborations with medical researchers for validating their diagnostic platforms against various cancers and cardiac conditions.
Vitaly Kheyfets, PhD, serves as Associate Professor in the Department of Pediatrics-Critical Care Medicine at the University of Colorado Anschutz Medical Campus School of Medicine, where he directs research at the intersection of pediatric critical care and cardiopulmonary pathophysiology with emphasis on pulmonary arterial hypertension (PAH). His primary research focuses on right ventricular adaptation to pulmonary hypertension, utilizing machine learning-driven multi-omics analysis to identify disease biomarkers and molecular networks. He pioneers computational fluid dynamics approaches for hemodynamic modeling in congenital heart conditions like Glenn physiology, while also investigating sleep oscillatory patterns as neurodegenerative biomarkers. His methodology integrates proteomics, spatial transcriptomics, and pressure waveform analysis to dissect vascular remodeling mechanisms. Publication trends reveal a strong emphasis on translating computational models into clinical applications for PAH prognostication, with recent work developing AI-cooperative diagnostic platforms and characterizing microvascular changes in the right ventricle. Cross-disciplinary collaborations span proteomics, imaging, and sleep neuroscience, demonstrating consistent innovation in both pulmonary hypertension and neurodegenerative disease biomarker discovery.
Deepak Ganesan is a Professor at the Manning College of Information and Computer Sciences (CICS) at the University of Massachusetts Amherst. His research focuses on low-power sensing and communication, networked systems, and machine learning applied to pervasive health monitoring and societal challenges. PhD, Computer Science, University of California, Los Angeles (2004) MS, Computer Science, University of California, Los Angeles (2000) BTech, Computer Science, Indian Institute of Technology, Madras (1998) Ganesan's work bridges wireless sensor networks, smart textiles, and healthcare applications. He designs ultra-low-power wearable devices for tracking health signals like drug use, smoking, and cognitive performance, often integrating machine learning for robust detection. His research emphasizes societal impact, particularly in aging and Alzheimer's care through the Massachusetts AI and Technology Center for Connected Care (MassAITC) and the Center for Personalized Health Monitoring (CPHM). Recent publications highlight innovations in edge-cloud collaboration, fabric-based sensors, and longitudinal health analytics. His NIH-funded MD2K Center for Excellence and affiliations with the Center for Data Science and Computational Social Science Institute further underscore his interdisciplinary approach. ACM Fellow NSF CAREER Award (2006) IBM Faculty Award (2008) UMass Junior Faculty Fellow (2008) UMass Lilly Teaching Fellow (2009) Best Paper at CHI 2013 Best Paper Runner-up at Mobicom 2014 Honorable Mentions at Ubicomp 2013 Ganesan leads the SENSORS: Wireless Sensor Networks Group and contributes to global initiatives like the Internet of Battlefield Things. His work spans academic research, industry partnerships, and policy development in AgeTech and digital health.
Dr. Mark Gardner is a Research Fellow in Clinical Imaging at the ACRF Image X Institute, part of the University of Sydney's Sydney School of Health Sciences and Faculty of Medicine and Health. His work focuses on advancing radiation therapy and medical imaging technologies, with particular emphasis on improving treatment accuracy and patient comfort. Gardner holds a PhD from Flinders University, completed in collaboration with the Medical Device Research Institute, and has held research roles at the Cystic Fibrosis Airway Research Group (CFARG). His current projects include the Nano-X radiation therapy device and the Remove the Mask initiative , which aims to eliminate immobilization masks in head and neck cancer treatments. Gardner is affiliated with organizations like the IEEE Engineering in Medicine and Biology Society and the American Association of Physicists in Medicine. Research interests span radiation oncology, translational research in medical imaging, and device innovation. His work integrates advanced imaging techniques (e.g., synchrotron X-rays, cone-beam CT) with machine learning and wearable sensors to address challenges in respiratory therapy and tumor targeting. Notable contributions include developing real-time motion tracking for radiation therapy and improving mucociliary transport measurements. Awards: FameLab 2020 State Finalist, 2018 Medtech e-Challenge Winner, 2017 3MT Runner-Up Grants/Projects: Nano-X radiation therapy development, Remove-the-Mask surface-guided system Collaborations: Industry partnerships, multi-institutional research networks Gardner advises Chen Cheng on real-time head/neck motion monitoring during radiation therapy. His lab contributes to open-source tools and preclinical imaging advancements, bridging engineering and clinical oncology.
